Saule Balmagambetova is the Principal Investigator for the PrEDiCaTE study. Saule holds a certificate in clinical research from Harvard Medical School (2013) and a PhD in Gynecologic Oncology from the West Kazakhstan Medical University, Aktobe (2018). Specializing in the field of women's cancers, Saule is particularly interested in the cardiotoxicity of breast cancer chemotherapy.
Zhenisgul Tlegenova is the Coordinator for the PrEDiCaTE study. Zhenisgul holds a certificate in Clinical Cardiology from the Cardioline Heart Institute, Israel (2008) and a PhD in Cardiology from the West Kazakhstan Medical University, Aktobe (2020). Specializing in cardiac dysfunction, Zhenisgul is particularly interested in cardio-oncology issues.